<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immunotherapy integration &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immunotherapy-integration/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 13 Aug 2025 15:18:54 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>immunotherapy integration &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Promising Neoadjuvant Immunochemoradiotherapy for MSS/pMMR Rectal Cancer</title>
		<link>https://bioengineer.org/promising-neoadjuvant-immunochemoradiotherapy-for-mss-pmmr-rectal-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 13 Aug 2025 15:18:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[immunotherapy integration]]></category>
		<category><![CDATA[locally advanced rectal cancer]]></category>
		<category><![CDATA[MSS/pMMR rectal cancer]]></category>
		<category><![CDATA[neoadjuvant immunochemoradiotherapy]]></category>
		<category><![CDATA[Tumor microenvironment modulation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/promising-neoadjuvant-immunochemoradiotherapy-for-mss-pmmr-rectal-cancer/</guid>

					<description><![CDATA[In recent years, the landscape of oncology has undergone a transformative evolution, particularly in the treatment of rectal cancer. Traditional modalities, including surgery, chemotherapy, and radiotherapy, have long stood as the pillars of care. However, the advent of immunotherapy has revolutionized therapeutic strategies across diverse malignancies. A groundbreaking study by Yang et al., published in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">255441</post-id>	</item>
	</channel>
</rss>
